Moderna surprises the Street by predicting a bigger-than …

Moderna Stock Crashes 21% After Covid Vaccine Maker Slashes …

2 weeks from now

2 days ago  · Moderna stock crashed Monday after the Covid vaccine maker slashed its outlook for 2024 and 2025 sales and announced an expanded cost-cutting initiative.. ↑ X

investors.com

Moderna Cuts 2025 Sales Forecast By $1 Billion On Weak Vaccine …

2 weeks from now

2 days ago  · (Reuters) -Moderna (MRNA) cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) shot and weak demand for COVID …

yahoo.com

Moderna's $1 Billion Revenue Forecast Cut Sends Stock

2 weeks from now

2 days ago  · Shares of Moderna dropped more than 20% intraday to $33.44, more than erasing gains last week after the first bird-flu death was reported in the U.S. The stock has lost about …

investopedia.com

Moderna Stock Jumps After Covid Vaccine Obliterates Sales …

2 weeks from now

Aug 3, 2022  · Moderna also reiterated its view for $21 billion in full-year sales of its Covid vaccine. Analysts called for $22.2 billion in total revenue. Further, the company announced a new …

investors.com

Moderna's Stock Pops After Surprise Quarterly Profit, Even As …

2 weeks from now

Feb 22, 2024  · Moderna Inc. shares (MRNA) jumped more than 7% premarket on Thursday after the company reported a surprise fourth-quarter profit, even as its COVID product sales …

morningstar.com

Why Moderna Stock Just Crashed 21% - Nasdaq

2 weeks from now

2 days ago  · Moderna's (NASDAQ: MRNA) sales are slowing down, and Moderna stock is going down -- a lot.. The coronavirus vaccine maker's shares plunged 21.2% through 10:20 a.m. ET …

nasdaq.com

Moderna Stock Plunges Nearly 17% After Company Lowers 2025 …

2 weeks from now

Moderna now expects 2025 revenue of between $1.5 billion and $2.5 billion, most of which will come in the second half of the year. The majority of those sales will come from Moderna's …

msn.com

Moderna Stock Jumps After Company Posts Surprise Quarterly …

2 weeks from now

The results cap a rocky year for the biotech company and other Covid vaccine makers. Moderna reiterated its full-year 2024 sales guidance of roughly $4 billion.

msn.com

Moderna Stock Surges 14% After Covid Vaccine-Maker Surprises …

2 weeks from now

Feb 22, 2024  · During the fourth quarter, sales declined 45% year over year, "primarily due to a reduction in sales of the company's Covid-19 vaccine," Moderna said in its news release. …

investors.com

Moderna Shares Jump On 2025 Sales Growth Goal | CTV News

2 weeks from now

Jan 2, 2024  · Moderna shares gained nearly 14% on Tuesday as brokerage Oppenheimer upgraded the stock to "outperform" and the vaccine maker's CEO reiterated the company's …

ctvnews.ca

Vaccine Stocks Surge: Moderna Jumps 11% As COVID-19 And Flu …

2 weeks from now

Jan 7, 2025  · Tuesday saw bumps in Moderna (NASDAQ:MRNA), Novavax (NASDAQ:NVAX), and other vaccine producers as worries about rising COVID-19 and flu infections in the United …

yahoo.com

Moderna Stock Jumps After Reporting $4.2 Billion In Vaccine Sales ...

2 weeks from now

Aug 5, 2021  · Moderna posts stronger-than-expected second-quarter earnings while boosting its forecast for 2021 vaccine sales to around $20 billion. 'We are pleased that our COVID-19 …

thestreet.com

Moderna Stock Surges After Covid Shot Obliterates Sales Views

2 weeks from now

May 4, 2022  · Despite a nearly $2 billion sales beat, Moderna restated its prediction for $21 billion in full-year advance purchase agreements for its two-shot Covid vaccine. The projection was …

investors.com

Moderna Price Levels To Watch After Stock's 12% Surge On Tuesday

2 weeks from now

Jan 8, 2025  · Moderna shares soared as investors placed bets that the pharmaceutical giant’s development of an H5N1 bird flu vaccine could boost sales after the first death linked to the …

investopedia.com

Moderna Surges After CDC Reports Two-Week Covid Spike

2 weeks from now

Jan 7, 2025  · BioNTech and Novavax's Covid shots make up the entirety of their product sales. Moderna stock popped 11.7% to 47.53, while BioNTech shares 5.6% to 126.88. ... The lion's …

investors.com

Moderna Stock Gains On Better-Than-Expected Covid-19 Vaccine …

2 weeks from now

Nov 7, 2024  · Covid vaccine sales totaled $1.8 billion for the third quarter. That blew past analysts’ estimates of $1.2 billion, and was slightly higher than a year earlier. Moderna's stock …

wsj.com